Comparison of 18F-FDG PET/CT imaging with different dual time 18F-FDG PET/CT with forced diuresis in clinical diagnosis of prostate cancer

被引:2
作者
Yu, Longhua [1 ]
Huang, Shiming [2 ]
Wu, Siyu [3 ]
Yue, Jianlan [2 ]
Yin, Liang [2 ]
Lin, Zhichun [2 ,4 ]
机构
[1] Hosp 971 Navy Chinese PLA, Dept Nucl Med, Qingdao, Shandong, Peoples R China
[2] Pingjin Hosp, Characterist Med Ctr Chinese Peoples Armed Police, Dept Nucl Med, Tianjin, Peoples R China
[3] Pingjin Hosp, Characterist Med Ctr Chinese Peoples Armed Police, Dept Obstet & Gynecol, Tianjin, Peoples R China
[4] Pingjin Hosp, Characterist Med Ctr Chinese Peoples Armed Police, Dept Nucl Med, 220 Chenglin Rd, Tianjin 300162, Peoples R China
关键词
F-18-FDG; PET; CT; prostate cancer (PCa); SUVmax; COLORECTAL-CANCER; FDG-PET; POINT; BENIGN;
D O I
10.1097/MD.0000000000032331
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of this study was to compare the capability of different dual time (interval 1, 2, 3, or 4 hours) 18F-fluorodeoxyglucose (F-18-FDG) positron emission tomography/computed tomography (PET/CT) with forced diuresis to diagnose prostate cancer (PCa). A retrospective review of 273 male patients from March 2009 to June 2019, with any focal F-18-FDG uptake in the prostate gland during PET/CT imaging. Early PET/CT imaging was performed 60 minutes after FDG injection. Delayed imaging was performed 1 to 4 hours after diuretic injection. For prostate lesions with increased F-18-FDG uptake, a spheroid-shaped volume of interest was drawn, including the entire lesion, and the maximum standard uptake value (SUVmax) of the lesion was measured. The SUVmax > 2.5 after delayed imaging and the retention index > 15% were used as the diagnostic criteria for PET/CT in the diagnosis of PCa. Otherwise, it was diagnosed as the benign prostate disease. The final diagnosis was based on histological examination, associated imaging studies, or/and clinical follow-up. The results of inter-group comparison showed that the SUVmax of 1-, 2-, 3-, and 4-hour delayed imaging after diuresis in PCa group was significantly higher than that in control group (P < .05), but there was no statistical difference in SUVmax of early imaging between PCa and control group (P > .05). And the retention index of PCa group that delayed 1, 2, 3, and 4 hours after diuresis were significantly higher than those of control group, respectively (P < .05). The diagnostic sensitivity of imaging delayed 1, 2, 3, and 4 hours after diuresis was 68.8%, 81.2%, 85.7 %, and 71.4%, the specificity was 52.5%, 74.5%, 70.6%, and 65.0%, and the accuracy was respectively 58.2%, 77.4%, 76.4%, and 67.6%, the positive predictive values were 44.0%, 68.9%, 64.3%, and 58.8%, and the negative predictive value were 75.6%, 85.4%, 88.9%, and 76.5%, respectively. F-18-FDG PET/CT imaging as an imaging tool lacks certain specificity in the diagnosis of PCa, regardless of whether the imaging is delayed. The main advantage of delayed diuretic imaging in PCa is that it can significantly improve the sensitivity, especially the diagnostic effect delayed 2 hours after diuresis is better.
引用
收藏
页数:5
相关论文
共 30 条
[1]   Public reporting of outcomes in radiation oncology: the National Prostate Cancer Audit [J].
Aggarwal, Ajay ;
Nossiter, Julie ;
Parry, Matthew ;
Sujenthiran, Arunan ;
Zietman, Anthony ;
Clarke, Noel ;
Payne, Heather ;
van der Meulen, Jan .
LANCET ONCOLOGY, 2021, 22 (05) :E207-E215
[2]   Impact of Dual-Time-Point F-18 FDG PET/CT in the Assessment of Pleural Effusion in Patients With Non-Small-Cell Lung Cancer [J].
Alkhawaldeh, Khaled ;
Biersack, Hans-J ;
Henke, Anna ;
Ezziddin, Samer .
CLINICAL NUCLEAR MEDICINE, 2011, 36 (06) :423-428
[3]   The value of18F-FDG PET/CT for predicting or monitoring immunotherapy response in patients with metastatic melanoma: a systematic review and meta-analysis [J].
Ayati, Narjess ;
Sadeghi, Ramin ;
Kiamanesh, Zahra ;
Lee, Sze Ting ;
Zakavi, S. Rasoul ;
Scott, Andrew M. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (02) :428-448
[4]   Optimizing delayed scan time for FDG PET: Comparison of the early and late delayed scan [J].
Chen, Yu Mei ;
Huang, Gang ;
Sun, Xiao Guang ;
Liu, Jian Jun ;
Chen, Tao ;
Shi, Yi Ping ;
Wan, Liang Rong .
NUCLEAR MEDICINE COMMUNICATIONS, 2008, 29 (05) :425-430
[5]   When should we recommend use of dual time-point and delayed time-point imaging techniques in FDG PET? [J].
Cheng, Gang ;
Torigian, Drew A. ;
Zhuang, Hongming ;
Alavi, Abass .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 (05) :779-787
[6]   MRI-Targeted or Standard Biopsy in Prostate Cancer Screening [J].
Eklund, Martin ;
Jaderling, Fredrik ;
Discacciati, Andrea ;
Bergman, Martin ;
Annerstedt, Magnus ;
Aly, Markus ;
Glaessgen, Axel ;
Carlsson, Stefan ;
Groenberg, Henrik ;
Nordstroem, Tobias .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (10) :908-920
[7]   Histological comparison between predictive value of preoperative 3-T multiparametric MRI and68Ga-PSMA PET/CT scan for pathological outcomes at radical prostatectomy and pelvic lymph node dissection for prostate cancer [J].
Franklin, Anthony ;
Yaxley, William J. ;
Raveenthiran, Sheliyan ;
Coughlin, Geoff ;
Gianduzzo, Troy ;
Kua, Boon ;
McEwan, Lousie ;
Wong, David ;
Delahunt, Brett ;
Egevad, Lars ;
Samaratunga, Hema ;
Brown, Nicholas ;
Parkinson, Rob ;
Roberts, Matthew J. ;
Yaxley, John W. .
BJU INTERNATIONAL, 2021, 127 (01) :71-79
[8]   Diagnostic accuracy of visual analysis versus dual time-point imaging with 18FFDG PET/CT for the characterization of indeterminate pulmonary noduleswith low uptake [J].
Grisanti, F. ;
Zulueta, J. ;
Rosales, J. J. ;
Morales, M., I ;
Sancho, L. ;
Lozano, M. D. ;
Mesa-Guzman, M. ;
Garcia-Velloso, M. J. .
REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2020, 40 (03) :155-160
[9]   Prediction of Time to Hormonal Treatment Failure in Metastatic Castration-Sensitive Prostate Cancer with 18F-FDG PET/CT [J].
Jadvar, Hossein ;
Velez, Erik M. ;
Desai, Bhushan ;
Ji, Lingyun ;
Colletti, Patrick M. ;
Quinn, David I. .
JOURNAL OF NUCLEAR MEDICINE, 2019, 60 (11) :1524-1530
[10]   MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis [J].
Kasivisvanathan, V ;
Rannikko, A. S. ;
Borghi, M. ;
Panebianco, V ;
Mynderse, L. A. ;
Vaarala, M. H. ;
Briganti, A. ;
Budaus, L. ;
Hellawell, G. ;
Hindley, R. G. ;
Roobol, M. J. ;
Eggener, S. ;
Ghei, M. ;
Villers, A. ;
Bladou, F. ;
Villeirs, G. M. ;
Virdi, J. ;
Boxler, S. ;
Robert, G. ;
Singh, P. B. ;
Venderink, W. ;
Hadaschik, B. A. ;
Ruffion, A. ;
Hu, J. C. ;
Margolis, D. ;
Crouzet, S. ;
Klotz, L. ;
Taneja, S. S. ;
Pinto, P. ;
Gill, I ;
Allen, C. ;
Giganti, F. ;
Freeman, A. ;
Morris, S. ;
Punwani, S. ;
Williams, N. R. ;
Brew-Graves, C. ;
Deeks, J. ;
Takwoingi, Y. ;
Emberton, M. ;
Moore, C. M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (19) :1767-1777